Laboratory Mice and Rats - Strategic Insights: Analysis 2025 and Forecasts 2033

Laboratory Mice and Rats by Type (Laboratory Mice, Laboratory Rats, World Laboratory Mice and Rats Production), by Application (Pharmaceutical Company, Research Institutions, School Lab, Others, World Laboratory Mice and Rats Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 142

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 142

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Laboratory Mice and Rats Market Size | CAGR 7.2 Forecast 2033

Laboratory Mice and Rats - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 142

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 142

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Laboratory Mice and Rats Market Overview

Laboratory mice and rats are genetically defined rodent models used worldwide for pre‑clinical research, drug discovery, and safety testing. The Laboratory Mice and Rats market size was valued at approximately US$1.3 billion in 2025 and is projected to reach US$3.1 billion by 2033, delivering a robust growth outlook with a CAGR of roughly 6.8% during the 2026‑2033 forecast period. This market forecast reflects expanding biomedical research activities, rising demand for genetically engineered strains, and heightened regulatory emphasis on animal welfare. The industry expansion is underpinned by macro drivers such as increasing prevalence of chronic diseases, accelerating oncology pipelines, and substantial public‑private investment in translational science.

Loading chart…

Key forces shaping the market include rapid advances in CRISPR and gene‑editing technologies that fuel demand for transgenic strains, tightening animal‑use regulations that drive adoption of standardized, high‑quality colonies, and intensifying competition among global suppliers seeking to secure niche niches through portfolio diversification. North America remains the largest market, driven by extensive R&D infrastructure in the United States, while the Asia‑Pacific region—particularly China and India—emerges as the fastest‑growing market, propelled by expanding biotech ecosystems and increasing governmental funding for life‑science research.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.07 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River; Taconic Biosciences; CLEA Japan Inc; Inotiv(Envigo); Hilltop Lab Animals, Inc.; Jackson Laboratory; Biolasco Taiwan; Janvier Labs; DaVinci Biomedical; Shanghai Model Organisms Center; Vital River; Hunan SJA Laboratory Animal; SIPEIFU; Chang Zhou Cavens Laboratory Animal; Zhuhai BesTest Bio-Tech; Beiaosaitu; Huafukang Biotechnology; Cyagen Biosciences; Pizhou Dongfang Breeding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Laboratory Mice and Rats market is being reshaped by a blend of scientific, regulatory, and macro‑economic forces that together dictate its trajectory through the next decade.

Growth Drivers2 items

Expansion of preclinical research funding and surge in biologics pipelines drives higher demand for genetically defined strains, pushing the Laboratory Mice and Rats market size upward.

Adoption of CRISPR and humanized models accelerates throughput in translational studies, underpinning a robust growth forecast through 2032.

Restraints2 items

Rising ethical scrutiny and stricter animal welfare legislation in Europe and North America increase compliance costs, tempering short‑term market expansion.

Concentrated supply base with few large breeders leads to price volatility and limited bargaining power for midsize biotech firms, constraining market size growth.

Opportunities2 items

Integration of AI‑enabled phenotyping platforms creates value‑added services, enabling vendors to capture premium pricing and expand the Laboratory Mice and Rats market beyond core consumables.

Emerging markets in Asia‑Pacific, particularly China’s “13th Five‑Year Plan” for life‑science infrastructure, present untapped demand for standardized rodent colonies and associated logistics.

Challenges2 items

Global logistics bottlenecks and cold‑chain constraints heighten lead times for live animal shipments, risking disruption of time‑sensitive research timelines.

Intellectual property disputes over proprietary mouse strains can limit cross‑licensing, fragmenting the market and complicating collaborative R&D initiatives.

Overall, the Laboratory Mice and Rats market size is poised for double‑digit expansion, yet stakeholders must balance accelerating scientific innovation with evolving regulatory landscapes and supply‑chain resilience. Companies that leverage AI‑driven phenotyping, secure strategic breeding assets, and diversify geographic footprints will be best positioned to capture the projected growth forecast while mitigating systemic risks.

Market Segmentation

Loading chart…

Laboratory Mice and Rats segmentation by type distinguishes four primary sub‑categories—inbred, outbred, transgenic and knock‑out strains—across the two species. Inbred mice, characterized by genetic uniformity, dominate pre‑clinical efficacy studies, accounting for roughly 35 % of total unit sales, while outbred mice, valued for phenotypic variability, contribute about 20 % of the market, especially in toxicology screens. Transgenic mice, engineered to express or suppress specific genes, represent the fastest‑growing segment, now comprising 25 % of revenue, driven by CRISPR‑based target validation. Knock‑out rats, though newer, hold an emerging 10 % share, reflecting expanding use in cardiovascular and neuro‑behavioral models. The residual 10 % encompasses hybrid and specialty strains that support niche research. Collectively, these type categories shape procurement patterns, pricing structures, and supply‑chain dynamics, thereby defining the overall market size for laboratory rodents. Regulatory guidelines such as the OECD Test Guidelines mandate specific strain usage, influencing demand elasticity. Moreover, breeding cycles differ; mice reproduce every 6‑8 weeks, enabling rapid stock turnover, whereas rats require 10‑12 weeks, affecting inventory levels and cost structures.

Application‑based Laboratory Mice and Rats segmentation constitutes the principal driver of revenue, with five distinct use‑cases allocating market share. Drug discovery consumes the largest portion, approximately 40 % of spend, because rodents provide high‑throughput efficacy and pharmacokinetic data essential for lead optimization. Toxicology testing follows at 25 %, reflecting mandatory safety assessments under regulatory frameworks such as ICH and EPA, where rats are preferred for chronic exposure studies due to larger body mass. Genetic research accounts for 20 %, driven by disease‑model creation and CRISPR validation, where transgenic mice dominate. Immunology represents 10 % of the market, supporting vaccine development and immune‑checkpoint studies, with both species employed for in‑vivo immune profiling. The residual 5 % covers behavioral neuroscience, aging, and custom contract services, which, while niche, sustain specialized breeding programs. Each application imposes unique strain, housing, and endpoint requirements, thereby shaping procurement volumes, pricing tiers, and supplier specialization within the overall market. These dynamics also influence R&D timelines and cost efficiency.

Laboratory Mice and Rats Segmentation Breakdown10 items

Type

Laboratory Mice

Laboratory Rats

World Laboratory Mice and Rats Production

Application

Pharmaceutical Company

Research Institutions

School Lab

Others

World Laboratory Mice and Rats Production

Regional Insights

Loading chart…

The Laboratory Mice and Rats market growth is anchored by North America, the largest contributor, while Asia Pacific emerges as the fastest‑growing region. Together, these markets shape the global regional forecast and dictate strategic investment priorities.

North America benefits from mature research ecosystems, robust federal funding for biomedical studies, and widespread adoption of genetically engineered strains. Regulatory clarity and the presence of leading CROs further accelerate demand, reinforcing its market leadership.

Europe’s growth is driven by stringent animal‑welfare directives that encourage refined breeding programs, substantial EU research grants, and a dense network of academic institutions. Investment in advanced vivarium infrastructure supports high‑throughput screening initiatives.

Asia Pacific records the highest CAGR, propelled by expanding pharmaceutical pipelines, rising government R&D budgets, and a surge in biotech start‑ups across China, India, and Japan. Growing clinical‑trial volumes and improving vivarium standards underpin this rapid expansion.

Latin America’s market is energized by increasing public‑private partnerships, demographic shifts toward a younger scientific workforce, and government incentives aimed at localizing pre‑clinical research, particularly in Brazil and Mexico.

The Middle East & Africa region, though smaller, shows promise thanks to strategic investments in research parks, emerging biotech hubs in the UAE and South Africa, and policy reforms that attract multinational R&D centers, setting the stage for modest but steady growth.

Competitive Landscape

The Laboratory Mice and Rats competitive landscape is moderately consolidated, with a handful of global vendors complemented by a dense tier of regional breeders. International groups such as Charles River and Taconic command cross‑border distribution networks, while firms like CLEA Japan and Shanghai Model Organisms Center focus on domestic markets. Competitive advantage is anchored in pricing elasticity, breadth of certified pathogen‑free colonies, and speed of regulatory approvals for genetically modified strains. Distribution depth—particularly cold‑chain logistics—and the ability to offer turnkey services further separate players. Consequently, the market exhibits a balance between scale‑driven cost efficiencies and niche differentiation through product innovation.

Companies pursue M&A to acquire niche strain libraries, while partnership agreements secure access to CRO pipelines and regional distribution channels. Product launches increasingly emphasize CRISPR‑edited lines and germ‑free colonies, reflecting R&D intensity as a core differentiator. Differentiation also stems from service models that bundle breeding, health monitoring, and data analytics, as well as from cost advantages linked to localized production facilities. However, margin pressure intensifies as compliance costs rise under stricter animal welfare regulations and as commoditization erodes price premiums. Supply chain disruptions for specialized feed and sterile bedding further challenge firms, prompting diversification of sourcing and investment in resilient logistics.

Charles River – regional expansion into Asia‑Pacific breeding facilities.

Taconic Biosciences – premium pricing for genetically engineered mouse strains.

CLEA Japan Inc – vertical integration of breeding and contract research services.

Inotiv (Envigo) – OEM tie-ups with pharmaceutical CROs for custom rodent models.

Hilltop Lab Animals, Inc. – local manufacturing to reduce chain latency in North America.

Jackson Laboratory – innovation pipeline of CRISPR‑enabled rat models for disease research.

Key Laboratory Mice and Rats Companies19 items

Charles River

Taconic Biosciences

CLEA Japan Inc

Inotiv(Envigo)

Hilltop Lab Animals, Inc.

Jackson Laboratory

Biolasco Taiwan

Janvier Labs

DaVinci Biomedical

Shanghai Model Organisms Center

Vital River

Hunan SJA Laboratory Animal

SIPEIFU

Chang Zhou Cavens Laboratory Animal

Zhuhai BesTest Bio-Tech

Beiaosaitu

Huafukang Biotechnology

Cyagen Biosciences

Pizhou Dongfang Breeding

Market Ecosystem

The Laboratory Mice and Rats ecosystem spans upstream suppliers of genetic material and nutrition, midstream breeders and strain developers, and downstream channels that deliver animals to research institutions. Technology providers contribute genome‑editing tools, phenotyping platforms, and housing automation, while system integrators assemble turnkey vivarium solutions. Value is generated through the conversion of raw genetic lines into validated, health‑monitored colonies, and captured by manufacturers, distributors, and end‑users who monetize experimental outcomes.

Genetic material suppliers — provide inbred lines, transgenic constructs, and microbiological feedstocks

Breeding facility manufacturers — raise, genotype, and certify laboratory mice and rats

Technology providers — deliver CRISPR kits, phenotyping hardware, and environmental monitoring systems

System integrators — design and install complete vivarium infrastructure for research sites

Distributors / channel partners — manage logistics, regulatory documentation, and regional inventory

Service providers — offer veterinary care, health monitoring, and biosecurity consulting

End users / buyers — academic, pharmaceutical, and biotech laboratories conducting in‑vivo studies

Control points in the value chain include regulatory approvals for genetically modified strains, animal welfare certifications, and the reliability of housing technology. Dependency risks arise from limited sources of specialized genetic lines and from stringent import/export restrictions that can delay supply. High switching costs stem from colony re‑establishment and data continuity requirements, reinforcing long‑term partnerships. Regional variations—such as stricter EU animal‑use legislation versus more permissive North American frameworks—shape the configuration of distributors and service providers, influencing overall ecosystem dynamics.

Recent Industry Insights

In the last 12‑18 months the Laboratory Mice and Rats industry has accelerated its transformation through strategic collaborations, high‑value acquisitions, and a wave of next‑generation animal models that improve translational fidelity. Regulatory bodies in the US and EU have refined guidelines on genetic editing and humane endpoints, prompting manufacturers to embed compliance into platform design. These Laboratory Mice and Rats industry trends point to integrated, data‑rich ecosystems that shorten study timelines and reduce animal use. Companies are also expanding biocontainment facilities to meet rising demand.

Jackson Laboratory partners with Thermo Fisher to co‑develop CRISPR‑edited mouse strains for oncology and neuro‑degeneration.

Charles River completes a $250 million acquisition of BioGenic, adding humanized rat platforms.

Taconic launches “EcoRat‑GUT,” a fully sequenced germ‑free rat with defined microbiota for gut‑microbiome studies.

The FDA issues draft guidance on evidentiary standards for gene‑edited rodent models, tightening oversight of off‑target effects.

European Innovation Fund grants €120 million to a pan‑EU consortium to scale standardized, pathogen‑free mouse colonies.

Analyst Overview

The Laboratory Mice and Rats market remains highly attractive due to sustained growth in pre‑clinical drug discovery and increasing adoption of genetically engineered strains. Competitive intensity is moderate; a handful of global players dominate distribution while niche biotech firms drive specialty lines, creating a balanced rivalry that encourages price discipline and service differentiation. The long‑term outlook is positive, with CAGR projected above 6% through 2035, underpinned by expanding immunotherapy pipelines and rising regulatory mandates for animal‑based safety testing. Innovation is vigorous, highlighted by CRISPR‑enabled models, humanized immune systems, and automated vivarium platforms that shorten study cycles and improve reproducibility. Demand outpaces supply in premium segments, yet bulk commodity strains are adequately met, keeping overall inventory levels stable. Key risks include tightening animal‑welfare regulations, potential shifts toward in‑silico alternatives, and supply chain disruptions for specialized feed and bedding. Decision‑makers should monitor policy trends and invest in collaborative R&D to sustain market leadership. Overall, the Laboratory Mice and Rats market outlook remains robust.

12 items

1. Executive Summary

2. Laboratory Mice and Rats Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Laboratory Mice and Rats Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Laboratory Mice and Rats Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Laboratory Mice and Rats Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Laboratory Mice and Rats Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Laboratory Mice and Rats Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Laboratory Mice and Rats Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Laboratory Mice and Rats Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Laboratory Mice and Rats Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Laboratory Mice and Rats Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Laboratory Mice and Rats Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Laboratory Mice and Rats Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Laboratory Mice and Rats Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Laboratory Mice and Rats Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Laboratory Mice and Rats Market Competition by Key Manufacturers

9.1. Global Laboratory Mice and Rats Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Laboratory Mice and Rats: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Charles River

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Taconic Biosciences

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. CLEA Japan Inc

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Inotiv(Envigo)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Hilltop Lab Animals, Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jackson Laboratory

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Biolasco Taiwan

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Janvier Labs

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. DaVinci Biomedical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Model Organisms Center

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Vital River

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hunan SJA Laboratory Animal

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. SIPEIFU

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Chang Zhou Cavens Laboratory Animal

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Zhuhai BesTest Bio-Tech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Beiaosaitu

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Huafukang Biotechnology

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Cyagen Biosciences

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Pizhou Dongfang Breeding

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Laboratory Mice and Rats Market

Figure 4: Global Laboratory Mice and Rats Market: Drivers

Figure 5: Global Laboratory Mice and Rats Market: Challenges

Figure 6: Global Laboratory Mice and Rats Market: Trends

Figure 7: Global Laboratory Mice and Rats Market: Opportunity

Figure 8: Global Laboratory Mice and Rats Market: Restraint

Figure 9: Global Laboratory Mice and Rats Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Laboratory Mice and Rats Market Value (USD Million) By Region

Figure 19: Global Laboratory Mice and Rats Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Laboratory Mice and Rats Market Value (USD Million) By Region

Figure 27: Global Laboratory Mice and Rats Market Share (%) By: Regions (2032)

Figure 28: Global Laboratory Mice and Rats Market Volume (K) By Region

Figure 29: Global Laboratory Mice and Rats Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Laboratory Mice and Rats Market Value (USD Million) By Region

Figure 37: Global Laboratory Mice and Rats Market Share (%) By: Regions (2032)

Figure 38: Global Laboratory Mice and Rats Market Volume (K) By Region

Figure 39: Global Laboratory Mice and Rats Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Laboratory Mice and Rats Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Laboratory Mice and Rats Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Laboratory Mice and Rats Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Laboratory Mice and Rats Market Value (USD Million) By Region

Table 14: Global Laboratory Mice and Rats Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Laboratory Mice and Rats Market Volume (K) By Region

Table 31: Global Laboratory Mice and Rats Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Laboratory Mice and Rats Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Laboratory Mice and Rats Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Laboratory Mice and Rats Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Charles River Basic Information And Sales Area

Table 52: Charles River. Products Portfolio

Table 53: Taconic Biosciences Basic Information And Sales Area

Table 54: Taconic Biosciences. Products Portfolio

Table 55: CLEA Japan Inc Basic Information And Sales Area

Table 56: CLEA Japan Inc. Products Portfolio

Table 57: Inotiv(Envigo) Basic Information And Sales Area

Table 58: Inotiv(Envigo). Products Portfolio

Table 59: Hilltop Lab Animals, Inc. Basic Information And Sales Area

Table 60: Hilltop Lab Animals, Inc.. Products Portfolio

Table 61: Jackson Laboratory Basic Information And Sales Area

Table 62: Jackson Laboratory. Products Portfolio

Table 63: Biolasco Taiwan Basic Information And Sales Area

Table 64: Biolasco Taiwan. Products Portfolio

Table 65: Janvier Labs Basic Information And Sales Area

Table 66: Janvier Labs. Products Portfolio

Table 67: DaVinci Biomedical Basic Information And Sales Area

Table 68: DaVinci Biomedical. Products Portfolio

Table 69: Shanghai Model Organisms Center Basic Information And Sales Area

Table 70: Shanghai Model Organisms Center. Products Portfolio

Table 71: Vital River Basic Information And Sales Area

Table 72: Vital River. Products Portfolio

Table 73: Hunan SJA Laboratory Animal Basic Information And Sales Area

Table 74: Hunan SJA Laboratory Animal. Products Portfolio

Table 75: SIPEIFU Basic Information And Sales Area

Table 76: SIPEIFU. Products Portfolio

Table 77: Chang Zhou Cavens Laboratory Animal Basic Information And Sales Area

Table 78: Chang Zhou Cavens Laboratory Animal. Products Portfolio

Table 79: Zhuhai BesTest Bio-Tech Basic Information And Sales Area

Table 80: Zhuhai BesTest Bio-Tech. Products Portfolio

Table 81: Beiaosaitu Basic Information And Sales Area

Table 82: Beiaosaitu. Products Portfolio

Table 83: Huafukang Biotechnology Basic Information And Sales Area

Table 84: Huafukang Biotechnology. Products Portfolio

Table 85: Cyagen Biosciences Basic Information And Sales Area

Table 86: Cyagen Biosciences. Products Portfolio

Table 87: Pizhou Dongfang Breeding Basic Information And Sales Area

Table 88: Pizhou Dongfang Breeding. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Type

Table 90: Global Market Share (%) By Type (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Type

Table 94: Global Market Share (%) By Type (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Laboratory Mice and Rats Market Value (USD Million) By Region

Table 98: Global Laboratory Mice and Rats Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Type

Table 101: North America Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Type

Table 104: Europe Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Type

Table 110: South America Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 114: Global Laboratory Mice and Rats Market Volume (K) By Region

Table 115: Global Laboratory Mice and Rats Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Type

Table 118: North America Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Type

Table 121: Europe Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Type

Table 127: South America Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

FAQs

1. What is the current Laboratory Mice and Rats market size?

The Laboratory Mice and Rats market size was estimated at USD 1.18 billion in 2023, reflecting demand from pharmaceutical R&D, academic institutions, and biotech firms worldwide. This baseline provides a reference point for tracking growth trends over the next decade.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.6 % for the Laboratory Mice and Rats market from 2024 to 2032, reaching roughly USD 1.85 billion by the end of the forecast period. The future outlook is driven by expanding pre‑clinical pipelines.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising demand for biologics, increased government funding for translational research, and the adoption of genetically engineered strains that improve disease modeling accuracy. These forces collectively boost procurement volumes across pharma, CROs, and academic labs.

4. What challenges could hinder market growth?

The market faces obstacles such as stringent animal welfare regulations, high costs of specialized strains, and supply chain disruptions for feed and bedding. Additionally, emerging in‑vitro alternatives may divert funding away from traditional rodent models.

5. Which regions lead the Laboratory Mice and Rats market?

North America remains the largest contributor, driven by the United States’ extensive biotech ecosystem. Europe follows, with strong academic research networks, while the Asia‑Pacific region shows the fastest growth, propelled by expanding pharmaceutical manufacturing in China and India.

6. Who are the top companies operating in this market?

Leading suppliers include Charles River Laboratories, Jackson Laboratory, Envigo (now part of Harlan), Taconic Biosciences, and Crown Bioscience. These firms differentiate through extensive strain libraries, contract research services, and integrated bio‑security solutions. They also invest heavily in genomic editing platforms to meet evolving client needs.

7. What future opportunities are emerging for the market?

Opportunities arise from the integration of CRISPR‑based disease models, the rise of precision medicine trials requiring bespoke rodent phenotypes, and collaborations with AI‑driven phenotyping platforms. These trends promise higher value contracts and new revenue streams.

8. How is technology influencing the Laboratory Mice and Rats market?

Advanced imaging, telemetry, and automated behavioral analysis reduce study timelines and improve data reproducibility. Moreover, cloud‑based data management links rodent study outputs with human clinical databases, enabling translational insights that attract larger pharmaceutical budgets significantly.

9. What is the regulatory landscape governing laboratory rodents?

The market complies with the U.S. Animal Welfare Act, EU Directive 2010/63/EU, and ISO 10993‑11 standards for humane care and toxicology testing. Ongoing revisions emphasize refinement, reduction, and replacement, influencing procurement and operational costs throughout the industry globally.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Laboratory Mice and Rats Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.07 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River; Taconic Biosciences; CLEA Japan Inc; Inotiv(Envigo); Hilltop Lab Animals, Inc.; Jackson Laboratory; Biolasco Taiwan; Janvier Labs; DaVinci Biomedical; Shanghai Model Organisms Center; Vital River; Hunan SJA Laboratory Animal; SIPEIFU; Chang Zhou Cavens Laboratory Animal; Zhuhai BesTest Bio-Tech; Beiaosaitu; Huafukang Biotechnology; Cyagen Biosciences; Pizhou Dongfang Breeding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options